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IC-SP.IV-Dob caused an additional fall in LVPSP (4 = -17 :I: 6 mmHg; p < 
0.01). 
Conclusions: I) Receptor-mediated Cot' Endo stimulation modulates LV 
function in "Ix recipients; 2) Arg augments Cor End0 intiuence on LV function 
after Tx probably by providing more substrate for Cor Endo production of 
NO; 3) p.adranergic stimulation with Dob augments Cor Endo influence on 
LV function probably I~y potentiating the myocardial cerdiodppreesant action 
of NO. 
~ ' ~  Abnormal Magnitude and Orlentatlon of  
Oeformatlon and Reduced Rigid Body Motion 
Throughout the Left Ventricle In Healed Reperfused 
First Anteflor Infarction 
Chadas J. McCreery0 Lori Semonik, Walter J. Rogers, Thomas P. Power, 
Therase M. Theoboid, Nathanial Reichek, Christopher M, Kramer. 
MCP/Hahnemann University, Pittsburgh, PA 
To determine intramyocardial deformation and rigid body motion after healed 
repaffused first anterior myo~rdtal infarction (Mi), we used magnetic reso- 
nance tagging (MRI) in 11 patients (9 M, aged 54 :t: 14), 8 :t: 1 weeks post 
ML Peak CK was 3949 ~: 2061 and all had single vessel disease. Results 
were compared to 9 normal subjects (NL) {7 M, aged 30 ± 3). Breathhcld, 
segmented k-space tagged images were obtained with 7 mm thick short axis 
slices (n = 11 ± 1) spanning the left ventricle (LV). Mean EF by MRI was 
44 :t: ~.'=. S~pe intersections were used to create triangular tinlte etercents 
that were tracked f~om the undeformed state to end systole to measure the 
orthogonal principal strains, ~.1 (1 + greatest systolic stretch), ~.~ (1 - greatest 
systolic shortening), # (angular deviation of Z~ from the radial direction) and 
displacement D. Data from 3 slices (apex, mid & base) were averaged by 
region. Results -t- SD as shown: 
xl xt ~ (degrees) O(mm) 
Septum MI 1.05 :t: 0105 '~ 0.89 ± 0,-06-" 35 ± ~1" 3.7 ~ 1.7 
NI 1,17±0,07 0,82± 0,04 8±5 3.8±1,0 
Anterior MI 1.04 :t: 0.05* 0,83 ± 0.08" 37 ± 24" 4.6 4. 2.1 * 
N! 1.09±0.05 0.77±0,08 15±6 6.9±1.7 
Latera! MI 1.09 ± 0.05" 0.84 ± 0.06" 27 ±21" 4.5 ± 2.1" 
NI 1,15±0,07 0.75 ± 0,05 7±4 6.6± 1.S 
Inferior MI 1.03 ± 0,05" 0.85 ± 0,08 # 23 ± 16 # 4.4 ± 2,5 # 
NI 1.09±e,o6 o.81 ±o,07 16±11 5.7± 1.8 
"p < 0,01 versus normal #p < 0.05 verpus normal. 
Following healed repedueed first anterior Mi the magnitude andorientatlon 
of deformation are abnormal and displacement is reduced throughout the LV. 
This may reflectglobal changes in mechanical oad or regional reorganization 
of myocardial architecture after infarct healing. 
Ti le Severity of  Functional Mitrel Regurgitation in 
Acute Myocardial Infarction Is Related to Left 
Ventrioular Shape 
Mohsin Alam, Omar Nass, Sidney Goidstelo, Famed KhaJa, George Divine, 
Lois Graham, Stevon Borzak, Howard Roeman, Hant N, Sabbeh. Henry 
Ford Heart and Vascular Institute, Detroit, Mf 
The elm of the study was to examine tt~ relationship between functional 
mitrai regurgitation (MR) and left vantrlcutar (LV) shape and function in the 
setting of acute myocardial Infarctlen (Mr). Two.dimensional echocardtogram 
with color flow Doppler studies were prospectively performed in 103 patients 
with first Q or non-Q wave MI within 48 hours ot admission. The maximum 
mitral regurgltant |et by color flow was graded mild if the }et area < 20% of 
left atrial (LA) area, moderate if 20--4~/o of LA area, and severe if > 40% LA 
area. The left ventricutar sphericity index was assessed based on the ratio 
of LV major.to-minor axis during end-systole (EAR) and end-diastole (EDR). 
MR No EDR ESR EF (%) 
None or Mild 81 1.9 • 0.3 2.1 :~ 0,5 52.3 d: 12.3 
Moderate 18 1.6 ± 0,2 1,7 ~ 0.3 53.6 :l: 9,6 
Severe 4 1.5±0,2 1.3 d: 0,1 40 ±12.5 
Anova P.value P ,* 0,01 P = 0.002 P - 0,116 
In conclusion, This data indicates that in patients with acute myocardial 
infarction the degree of MR is related to sphericity of the left ventricle and not 
to ejection fraction. 
cardioprotect ion During Chemo- and Redlotherapy 
for Neoplastk~ Dlseaee 
Beat C. Aascht~cher, Phtlipp Wagl, Martin Flud, Anion Fikrle, 
Bernhard Meier. CarcltolOg~, Univers/ty Hospital, Bern, Switzerland 
Objectives: To assess the cardioprote¢tlva value of an antloxidant regimen 
lAD), including N-acetylcysteine, vitamins E and C, in patients receiving high 
dose theme- (CT) and/or radiotheraw (RT) for malignant disease. 
Methocls: Prospective, placebo (PL) controlled, randomized and Clouble 
blinded pilot study Involving 14 patients receiving CT and 12 patients receiv- 
ing RT. 
Results:The main results are shown (mean :!: SD): , 
All tn = 2e) .... CT (n = 14) " P~T (n = 12) 
AO PL AO PL AO PL 
.e-lo,e as • 4% 87 ~ 8% .......... ~2 .  ~o 63 ± ~% 64 ~ 8% '" 70 ~ s% 
After 63~4% 61±6% 63:~L:~a 81±5% 64~:5% 60±4% 
Dlff n.s. p < 0.05 n,s. n.s, n.s. p < 0.05 
~'. > 10% 0% 46% 0% P-.5% 0% 66% 
(0/13) (6/13) (0/6) (2/8) (0/6} (4/6) .............. ,, ,,,,,,,,~ 
Before: Ejection fraction before chemo-/rSdiotherspy. After; Ejection traction after chemo- 
/rasdiotherapy. Diff.: Difference between Before and After. ~, > 1 (P/e: Ejection fraction de- 
creased more than 10% 
NO patient in the AO group showed detedoretion of ejection fraction of 
more then 10%. The ejection fraction of the whole study population and all 
subgroups receiving AO did not decrease significantly. 
C~nclu$/on: Our results suggest efficient cardioprotection by this non- 
toxic, inexpensive, and well tolerated antioxidant drug combination of N- 
acelylcystalne, and vitamins E and C. Initiation of larger confirmatory studies 
iS strongly encouraged by these promising results. The small number of 
patients in this pilot study precludes a dal'mitive statement. 
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~ M I B G  Assessment of  Sympathetic Nervous 
System Activation in Congestive Heart Failure 
Michael W. Dee, Dong-Wei Gag, Carole Stiilsen, J, William O'Connell, Bias 
H, Botvinlck. Philip C. Umetl. University of California, San Francisco, CA 
Whether educed myocardial noreptnophrice (NE) and elevated plasma NE 
in CHF are due to activation of the SNS or abnom~l neuronal uptake remains 
contrcvorstaI. To address this problem, we studied the u]orake and washout 
kinetics of 1-125 MIBG in rabbit hearts with moderate CHF (echo fi'actional 
shortening 27°/= vs 47% in controls, p < 0.02). Nonneuronai uptake of MIBG 
is absent in rabbit hearts, as in humans. Hence, early uptake of MIBG 
reflects neuronal ocalization. CHF was induced by the injection of 1 mg, q<g 
of adrlamycin (ADR) twice a week for 8 weeks. ADR treated rabbitS (n = 12), 
and control ral~its (n = 8) were anesthetized, ventilated, and the heart was 
imaged for three hours using a pinhole collimator, following the injection of 
770 :J: 90 uCi 1-125 MIBG. The hearts were then excised and biopsied for 
tissue NE, tissue MIBG, and sympathetic nerve histology. Image data was 
analyzed for heart to mediastinai ratio (HtJMed) at 15 minutes (early), 3 hours 
(tote), and MIBG washout (W/O). Arteri= blood was serried for ptesma NE. 
ADR treated hearts showed the following results relative to control hearts: 
Ht/Med (early) Hi/Meal ( ate) MIBG MIBG NE NE 
W/O Trssue ~ssue Plasma 
-0.2%* -30%** +28% °" -50% # --4 "/%! +129% = 
• p = ee,"p < O.01,ep < 0,05 
Sympathetic nerve morphology was normal. Initial MIBG uptake was nor- 
mal in CHF, suggesting presewed neuronal uptake, while MIBG washout 
was enhanced, consistent with activation Of the SNS. Activation of the SNS 
results in decreased MIBG overtime, which correlates with decreased tissue 
NE and elevated plasma NE. MIBG imaging allows noninvasive assessment 
Of dynamic changes in SNS activity in CHF, and may help to monitor the 
effects of therapy, 
Differential Effects of  Captopfi l  and Hydrelazlne on 
Autonomic Function in Cardiac Failure 
Nicholas E.R. Goedffe/d, Susanna J. Leiper, Keith A.A. Fox, Andrew 
O, Flapan. Royal Infirmary, Edinburgh, UK 
ACE Inhibitors and hydralazine (H) improve prognosis in patients with cardiac 
failure by slowing disease progression. In the VHEFT II and HY-C trials, ACE 
inhibition exhibited an advantage over H by reducing the incidence of sudden 
death. One passible mechanism to explain this would be differing effects on 
autonomic tone. 
We examined autonomic function following an oral dose of captopril 6,25 
